Group by: Creators | Item Type | No Grouping
Jump to: A | C | D | G
Number of items: 5.

A

Ayine-Tora, DM, Kingsford-Adaboh, R, Asomaning, WA, Harrison, JJEK, Mills-Robertson, FC, Bukari, Y, Sakyi, PO, Kaminta, S and Reynisson, J ORCID: https://orcid.org/0000-0003-4174-9512 (2016) Coumarin Antifungal Lead Compounds from Millettia thonningii and Their Predicted Mechanism of Action. Molecules, 21 (10).

C

Curley, P, Moss, DM, Siccardi, M and Owen, A (2016) Development and Validation of a LC-MS/MS Assay for the Quantification Of Efavirenz In Different Biological Matrices. Bioanalysis, 8 (20). pp. 2125-2134.

Curley, P, Rajoli, RK, Moss, DM, Liptrott, NJ, Letendre, S, Owen, A and Siccardi, M (2016) Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo Investigation. Antimicrobial Agents and Chemotherapy, 61 (1).

D

Davies, D, Heylings, JR, Gayes, H, McCarthy, T and Mack, MC (2016) Further development of an in vitro model for studying the penetration of chemicals through compromised skin. Toxicology in Vitro, 38. pp. 101-107.

G

Giardiello, M, Liptrott, NJ, McDonald, T, Moss, DM, Siccardi, M, Martin, P, Smith, D, Gurjar, R, Rannard, S and Owen, A (2016) Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies. Nature Communications, 7.

This list was generated on Fri Nov 3 07:38:19 2023 UTC.